To our knowledge, these results are the first to show that IL-17B/IL-17RB signaling promotes gastric tumorigenesis by upregulating the stemness of gastric cancer cells through activation of the AKT/β-catenin pathway. The gene discussed is AKT1; the disease is gastric cancer.